What is Mesosil?
Mesosil specializes in the development of next-generation anti-infective solutions, leveraging a unique silica-based platform that facilitates the high-capacity delivery and sustained release of bioactive agents. By integrating seamlessly into existing manufacturing workflows, the company provides a scalable solution for reducing recurrent tooth decay and enhancing the performance of implantable medical devices. Their technology represents a significant advancement in infection prevention, offering a robust defense mechanism that extends the functional lifespan of biomaterials in clinical settings.
How much funding has Mesosil raised?
Mesosil has raised a total of $1.6M across 1 funding round:
Angel/Seed
$1.6M
Angel/Seed (2024): $1.6M with participation from GreenSky Capital, NorthSpring Capital Partners, ArchAngel Network of Funds, Centre for Aging and Brain Health Innovation, and GreyHill Group
Key Investors in Mesosil
GreenSky Capital
Green Sky Ventures is an investment firm that focuses on early stage Canadian B2B start-ups led by exceptional entrepreneurs, emphasizing thorough diligence and significant capital deployment.
NorthSpring Capital Partners
NorthSpring Capital Partners invests in passionate entrepreneurs and companies developing unique intellectual property, providing financial resources to accelerate growth in the Toronto-Waterloo technology corridor.
ArchAngel Network of Funds
Archangel is a Canadian investment network focused on early-stage companies, seeking out resilient founders who tackle significant challenges through advanced technology and competitive advantages.
What's next for Mesosil?
Following this major strategic investment, Mesosil is poised to expand its operational footprint beyond dental applications into the high-growth orthopedics and implantable device sectors. The company's roadmap focuses on deepening its manufacturing partnerships and refining its bioactive delivery systems to meet rigorous regulatory standards. By leveraging the expertise of its diverse investor base, Mesosil aims to solidify its market position as a leader in material-based infection control, ultimately driving long-term value through sustained innovation and strategic market penetration.
See full Mesosil company page
